Michel Sadelain, MD, PhD Director, Center for Cell Engineering, Memorial Sloan Kettering Cancer Center 2017 Canada Gairdner Research Symposium October 27, 2017
Пікірлер: 5
@sodomdamager3 жыл бұрын
A great presentation. Thanks for sharing
@dr.satyajeetsalunkheph.d.43673 жыл бұрын
Great work
@SusieAspen2 жыл бұрын
I had aphasia from oxaliplatin infusion; the nurses were not prepared for my reaction!!! I guess you have to weigh the side effects with the outcome, but it doesn't look like it's ready for colon cancer quite yet...but maybe in a couple of years there will be a new immunotherapy for colon cancer. What corporations produce these new therapies, by the way.